| Business Summary | | Cell
Robotics
International,
Inc.
manufactures,
markets
and
sells
sophisticated
laser-based
medical
devices
and
scientific
research
instruments.
The
Company's
primary
focus
is
distributing
and
selling
its
laser-based
medical
device
to
consumers,
hospitals,
clinics
and
doctors'
offices.
Cell
Robotics'
product
lines
include
a
laser-based
medical
device
that
uses
a
laser
to
draw
a
blood
sample
to
allow
diabetics
to
measure
their
glucose
levels,
and
the
laser-based
research
workstation
marketed
under
the
name
Cell
Robotics
Workstation.
The
Company
had
also
produced
and
marketed
the
In
Vitro
Fertilization
Workstation
(IVF
Workstation).
The
IVF
Workstation
and
associated
technology
were
sold
to
Hamilton
Thorne
Research
in
May
2000
for
cash
and
future
royalty
payments
of
12%
of
net
sales
of
the
IVF
Workstation
and
related
technology. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cell
Robotics
develops,
manufactures
and
markets
a
series
of
laser-based
medical
devices
with
applications
in
the
blood
sample
collection,
skin
resurfacing
and
in
vitro
fertilization
markets.
For
the
six
months
ended
6/30/01,
revenues
rose
34%
to
$650
thousand.
Net
loss
fell
3%
to
$1.5
million.
Revenues
reflect
higher
scientific
research
instrument
sales
and
increased
research
grants.
Net
loss
was
partially
offset
by
lower
gross
margin
and
increased
marketing
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Ronald Lohrding, Ph.D., 60 Chairman,
Pres and CEO | $122K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|